Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press coverage in Publications and Media, and critical scientific insights within Industry News.

Mouse microbes may make scientific studies harder to replicate

Science features Taconic's Jennifer Phelan in this write-up due to her knowledge of how mouse microbiota impacts studies: "In the first experiment, Laura McCabe's lab seemed to hit a home run. The physiologist and her team at Michigan State University (MSU) in East Lansing were testing how a certain drug affects bone density, and they found that treated lab mice lost bone compared with controls. "I was...

Read More

Special Report on Cancer: An ever-evolving picture

DDNews features Dr. Megan MacBride in this composition due to her expertise in regards to how the role of mouse models have advanced oncology research and tumor heterogeneity: "It's summer and your family has decided to take a cottage vacation. Without television, internet or cell service, the nights are quiet; too quiet for the kids. Scrounging for activities, you find an old jigsaw puzzle and hope that...

Read More

Better Dirty: Getting the Dirt on Mouse Models

Biocentury highlights Taconic's Dr. Michael Seiler because of his knowledge in the field of immunology and mouse models: "While squeaky-clean mouse husbandry has established standardized, reductionist models of mammalian physiology, the practice might be limiting the effective translation of mouse research, especially in the age of immunotherapy, according to two academic teams who have characterized how getting mice "dirty" changes the animals' immunological baselines and responses to...

Read More

Taconic Biosciences and Life Technologies Partner to Strengthen Presence in India and the Middle East

Hudson, New York, May 5, 2016 - Taconic Biosciences, a leading provider of genetically modified solutions to researchers worldwide, announced its partnership with Life Technologies (India) Pvt. Ltd. to provide Taconic mouse models and services to researchers in India and the Middle East. "The partnership with Life Technologies strengthens our distribution network in India and parts of the Middle East and enables us to provide greater access...

Read More

Diagnosing CNS Diseases

PharmaVOICE highlights Taconic due to their experience with new technologies that assist with diagnosing CNS Diseases: "Neurological disorders comprise more than 600 conditions that affect the nervous system, impacting an estimated 50 million Americans every year. In the last few years, a tremendous push for new research of the brain has begun, in part, enabled by the National Institutes of Health BRAIN Initiative. Recent awards aim to...

Read More

Sink or Swim Time with ADME/Tox

Genetic Engineering & Biotechnology news features Taconic Biosciences because of their knowledge of animal models in ADME-Tox applications: "To Focus Your Resources and Develop the Next Winning Drug, Try More Rigorous Assays and Models. It may sound harsh, but drug candidates that are bound to be poor performers should be identified sooner rather than later--and ruthlessly eliminated from development. Granted, early in development, drugs tend to wade...

Read More

Much-improved mouse models

DDNews highlights Taconic's Dr. Michael Seiler due to his expertise and knowledge of the model huNOG-EXL: "According to Dr. Michael Seiler, associate director of genetically engineered models design and precision research models at Taconic Biosciences, "The major challenge in bridging clinical efficacy in drug development is predicting efficacy from animal models. We need a model that predicts human immunology, so we have created a uniquely suitable host...

Read More

The role of immunodeficient animal models in advancing immuno-oncology research

Drug Discovery World features Dr. Michael Seiler as the author and he discusses immunodeficient models, advances in human immune system models, and immuno-oncology studies and applications: "From inbred wild-type to more advanced genetically-engineered strains, mouse models enable researchers to gain important insights into the complex biological underpinnings of human cancer. Among those, spontaneous and genetically engineered immunodeficient strains can be administered in both primary human tumour tissue...

Read More

Tipping the Balance in Microbiome Standoffs

Genetic Engineering & Biotechnology spotlights Taconic Biosciences, specifically with information about the human microbiome: "The Human Microbiome May Dispose Us toward Health or Illness On The Basis Of Tiny Shifts in Microbial Subpopulations. The human body is immersed in the microbial world; our microbiota takes care of us. Yet the microbiota is complex, and much remains unknown about its composition and function. Moreover, microbiota are subject to...

Read More

The Microbiome: A New Research Tool

PharmaVOICE features Taconic's Product Manager Jennifer Phelan who speaks openly about her knowledge of the microbiome: "Our bodies are home to trillions of microbes, including bacteria, fungi, and viruses. These microbes are essential; they help digest food, produce certain vitamins, and regulate the immune system. Until recently, little was known about these microbes, but advances in DNA sequencing are making it possible to analyze the human microbiome....

Read More